Further functional validation confirmed the roles of hsa-let-7i and TRAF1 affecting TAM sensitivity in a breast cancer cell line ZR-75-1, supported the values of our integrative omic analysis approach in the identification of novel biomarkers. The gene discussed is TRAF1; the disease is breast carcinoma.